medline.ch Urologie-Nephrologie

	Prediction of cardiovascular mortality based on iron metabolism in patients with cardiovascular-kidney-metabolic syndrome: development and validation of clinical predictive model. Eur J Med Res Aihaiti A, Saidaming A, Tuerxun H, Li N, Nijiati M. PMID: 41549278 [PubMed - as supplied by publisher]
	Interpretable machine learning using CT radiomics predicts pathological upgrading after secondary resection in non-muscle-invasive bladder cancer. BMC Cancer Rao XP, Zou XC, Yu ZJ, Yuan YY, Chao HC, Huang JB, Zeng T. PMID: 41549273 [PubMed - as supplied by publisher]
	Unveiling novel susceptibility genes for kidney stone disease by a cross-tissue transcriptome-wide association study. World J Urol Sun X. PMID: 41549149 [PubMed - in process]
	The importance of door to detorsion time in children diagnosed with testicular torsion - Every minute counts! J Pediatr Urol Shields LBE, Jawad K, Wu WJ, Rosenberg E. PMID: 41549042 [PubMed - as supplied by publisher]
	Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 Trial. Eur Urol Nagumo Y, Kimura T, Ishikawa H, Sekino Y, Maruo K, Mathis BJ, Kageyama Y, Ushijima H, Kamei J, Yamashita H, Azuma H, Nihei K, Naiki T, Tomita N, Kobayashi Y, Yoshio K, Matsumoto T, Yoshitake T, Osawa T, Nishioka K, Kita Y, Mizowaki T, Hattori K, Tsuzuki T, Hashimoto K, Nishiyama H. PMID: 41548990 [PubMed - as supplied by publisher]
	Impact of Chronic Kidney Disease on the Onset of Sepsis: A Systematic Review. Biol Pharm Bull Osa S, Enoki Y, Endo A, Kumamoto K, Kobayashi K, Komiya C, Satake N, Kawakami J, Yagi T, Taguchi K, Matsumoto K. PMID: 41548931 [PubMed - indexed for MEDLINE]
	Highly Repeatable Tissue Proteomics for Kidney Transplant Pathology: Technical and Biological Validation of Protein Analysis using LC-MS/MS. Lab Invest Hofstraat-Boersma R, Marx K, Blatnik R, Claessen N, Chojnacka A, Peters-Sengers H, Florquin S, Kers J, Corthals G. PMID: 41548757 [PubMed - as supplied by publisher]
	Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic advances. Biochim Biophys Acta Rev Cancer Zhang J, Zhang T, Song D, Xu D. PMID: 41548699 [PubMed - as supplied by publisher]
	Safety of metformin in chronic kidney disease and type 2 diabetes mellitus: a systematic review and meta-analysis. Eur J Pharmacol Patiño-Cardona S, Pascual-Morena C, Sequí-Domínguez I, Álvarez-Bueno C, Martínez-Martínez H, de Miguel-Brox M, Priego-Jiménez S, Martínez-Vizcaíno V. PMID: 41548682 [PubMed - as supplied by publisher]
	Cellular signaling and radioresistance in prostate cancer. Cell Signal Sosa GA, Crosswhite B, Kirschner AN. PMID: 41548628 [PubMed - as supplied by publisher]
	Adjuvant bacillus Calmette-GuÃ©rin (BCG) immunotherapy versus BCG combined with disitamab vedotin in BCG-naÃ¯ve high-risk non-muscle invasive bladder cancer with HER2 expression: A real-world study. Int Immunopharmacol Xu T, Wang K, Chen Y, Yu Y, Zhang W, Shen D, Zhang J, Geng J, Peng B, Yan Y, Yao X. PMID: 41548434 [PubMed - as supplied by publisher]
	Two Versus Five-Fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2): Interim Acute Toxicity Analysis of the Phase II Randomised Trial. Clin Oncol (R Coll Radiol) Romrattaphan R, Dankulchai P, Prasartseree T, Sittiwong W, Thaweerat W, Junlabut S, Nitipitch S. PMID: 41548387 [PubMed - as supplied by publisher]
	Current landscape and therapeutic prospects of indole hybrids for prostate cancer treatment: A mini-review. Eur J Med Chem Xu Z, Shi Y, Pan B, Wang H. PMID: 41548295 [PubMed - as supplied by publisher]
	Prognostic Impact of Initial Prostate Specific Antigen Half-Life After Abiraterone Acetate in High-Volume Metastatic Hormone-Sensitive Prostate Cancer: Who May Need Triplet Therapy? Prostate Suzuki K, Ueki H, Wakita N, Okamura Y, Bando Y, Hara T, Terakawa T, Hyodo Y, Chiba K, Teishima J, Miyake H. PMID: 41548191 [PubMed - as supplied by publisher]
	Incremental Predictive Value of the Oncotype Genomic Prostate Score for Adverse Pathology in Active Surveillance Candidates. Prostate Ozawa Y, Moschovas MC, Sandri M, Sharma R, Saikali S, Rogers T, Patel V. PMID: 41548137 [PubMed - as supplied by publisher]
	Clinical hurdles for curcumin and piperine nanoparticles in prostate cancer treatment: a bridge too far or a path to clinical reality? Expert Opin Drug Deliv Yakubu J, Tagit O, Pandey AV. PMID: 41548083 [PubMed - as supplied by publisher]
	IRF7 is a novel prognostic biomarker in kidney renal clear cell carcinoma. Sci Rep Fu S, Zhou W, Yin W, Chen Y, Cao L, Chen Y, Xiao Z. PMID: 41547907 [PubMed - as supplied by publisher]
	Association between sleep duration and diabetic kidney disease: a cross-sectional study based on the National health and nutrition examination survey database (2005-2020). Diabetol Metab Syndr Niu D, Zhang L, You Q, Zhao S. PMID: 41547797 [PubMed - as supplied by publisher]
	Generalizable Deep Learning for Prostate Cancer Risk Stratification: Multicenter Study Integrating (18)F-PSMA-1007 PET/CT and mpMRI. Acad Radiol Miao C, Sun H, Yao F, Hong T, Ren Z, Zhuang Y, Lin Q, Bian S, Yang Y, Lin Y. PMID: 41547629 [PubMed - as supplied by publisher]
	Response to comment on "Risk factors for incident or persistent SARC-F-defined sarcopenia in patients with end-stage kidney disease: a cohort study". J Formos Med Assoc Lee SY, Chao CT. PMID: 41547579 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 463924

Seite 1 von 23197

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung